Ultima Genomics

Ultima Genomics was founded in 2016 by Gilad Almogy, its CEO, with the aim of steadily lowering the cost of DNA sequencing.⁠[1]

On May 31, 2022, Ultima Genomics emerged from stealth with a high-throughput sequencing platform offering a $100 genome, disclosing about $600 million in funding from investors including General AtlanticGeneral AtlanticGeneral Atlantic is a global investment firm founded in 1980 that grew out of Chuck Feeney’s family investment business. Growth equity is at its core, and through GA Credit, BeyondNetZero and Actis it also invests in credit, the energy transition and infrastructure. As of June 30, 2026, its assets under management across all strategies were about $130 billion.Open the full entry, Andreessen HorowitzAndreessen HorowitzAndreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz. It invests from the seed stage through the growth stage and provides operational support to its portfolio companies.Open the full entry, D1 Capital, Khosla VenturesKhosla VenturesKhosla Ventures (KV) is an American venture capital firm founded in 2004 by Vinod Khosla, the founding CEO of Sun Microsystems, and headquartered in Menlo Park, California. It made heavy early bets on clean technology, became OpenAI’s first venture capital investor in 2019, and its portfolio also includes companies such as DoorDash, Block (formerly Square), Impossible Foods, and Rocket Lab.Open the full entry, Lightspeed, Marius Nacht, aMoon, Playground Global and Founders FundFounders FundFounders Fund is a venture capital firm founded in San Francisco in 2005 by Peter Thiel and his former PayPal colleagues Ken Howery and Luke Nosek. Run by partners who were entrepreneurs themselves, it argues that founders should keep more control and is known for betting on difficult technology projects in areas such as space, defense, and artificial intelligence. It was Palantir’s first institutional investor, has invested in SpaceX many times since 2008, and its other notable investments include Facebook, Airbnb, Stripe, and Anduril; as of March 2026 it had raised nine early-stage funds and four growth funds.Open the full entry. The company said it had spent the previous five years developing its sequencing architecture.⁠[2]

Early access sites included the Broad Institute of MIT and HarvardHarvard UniversityHarvard University is a private research university in Massachusetts, established by the Massachusetts Bay Colony legislature in 1636 and named in 1639 for early benefactor John Harvard. Its principal campuses are in Cambridge and the Allston and Longwood neighborhoods of Boston. It includes Harvard College, graduate and professional schools, and the Radcliffe Institute for Advanced Study. Two governing boards share oversight. Alan M. Garber was president as of October 2026, and the endowment stood at $56.9 billion at the end of fiscal 2025.Open the full entry (its first), the Whitehead Institute, Baylor College of Medicine, StanfordStanford UniversityStanford University is a research university in California founded by Leland and Jane Stanford in 1885 and opened in 1891.Open the full entry’s Center for Genomics and Personalized Medicine, Cancer Research UK and the New York Genome Center.⁠[2]

The platform, the UG 100, sequences on a 200 mm silicon wafer onto which reagents are deposited at the center and spun outward, removing the need to flush fluidic channels; the company said it could sequence a complete human genome in about 20 hours and expected broader commercial deployment in 2023.⁠[3]

The UG 100 sequencing platform was commercially launched in 2024.⁠[4][5]

In February 2025 Ultima Genomics introduced UG 100 Solaris, raising output by more than 50% to 10–12 billion reads per wafer and cutting pricing by 20% to $0.24 per million reads, which the company said enabled an $80 genome.⁠[5]

At launch, Solaris had been deployed at more than 15 UG 100 customer sites.⁠[5]

In 2026 Ultima Genomics launched the UG200 Series sequencers and Solaris 2.0 workflows. The dual-wafer UG200 Ultra is priced at $1.25 million and the single-wafer model has a U.S. list price from $850,000, upgradeable in the field to the Ultra; the series opened for purchase with shipments planned to begin in the second quarter of 2026.⁠[4]

The company planned Solaris 2.0 Max for the second half of 2026, with up to 20 billion reads per wafer, double the earlier Solaris output, and said paired-end sequencing was coming to the UG200 Series.⁠[4]

Products listed on the Ultima Genomics website include the UG 100 Sequencing Platform, the UG200 Series, ppmSeq, Solaris 2.0 and bioinformatics analysis, along with certified service providers and a Technology Access Program.⁠[6]

Ultima Genomics: Official website: https://www.ultimagenomics.com/ (opens in a new window).⁠[6]

X: Public account: https://x.com/ultimagenomics (opens in a new window).⁠[6]

LinkedInLinkedInLinkedIn is a social networking platform for professionals. It was founded in 2002 by Reid Hoffman and others, launched in 2003, and listed on the New York Stock Exchange in 2011; after Microsoft acquired it for approximately $26.2 billion in 2016, it became a wholly owned Microsoft subsidiary. Its revenue comes from membership subscriptions, advertising, and recruitment solutions.Open the full entry: Public profile: https://www.linkedin.com/company/ultimagenomics (opens in a new window).⁠[6]